Lebrikizumab (MILR1444A)

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lebrikizumab (MILR1444A), covering 2016-11-29 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids [Phase 2]

See pricing